𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate

✍ Scribed by Hoofnagle, Jay H.


Book ID
122447378
Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
555 KB
Volume
3
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Adenine arabinoside 5β€²-monophosphate tre
✍ Jay H. Hoofnagle; Gerald Y. Minuk; Geoffrey M. Dusheiko; Daniel F. Schafer; Rodn πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 489 KB

Six patients with chronic type B hepatitis were treated with adenine arabinoside 5'-monophosphate at a dosage of 10 to 15 mg per kg per day for 10 days. All demonstrated an immediate and marked decrease in serum hepatitis B virus DNA and DNA polymerase, and 5 of the 6 became negative for both marker

Treatment of chronic type B hepatitis wi
✍ Jay H. Hoofnagle; Gary L. Davis; Reginald G. Hanson; S. Chris Pappas; Marion G. πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 533 KB

Ten patients with chronic type B hepatitis were treated with three courses of adenine arabinoside monosphosphate (Ara-AMP). The drug was given intramuscularly at a dosage of 10 mg/kg/day in ten-day courses during each of three sequential months. The patients were all men, aged 31-61 years, who were

Comparative use of adenine arabinoside a
✍ J. L. Vilde; F. Bricaire; A. Huchon; F. Brun-Vezinet πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 270 KB

Adenine arabinoside monophosphate (ARA AMP) was used in ten immunosuppressed patients suffering from varicella or disseminated zoster, and compared to adenine arabinoside (vidarabine) in ten other similar patients. Good results were obtained with both drugs: the fever stopped suddenly in three or fo